All sponsors

Kriya Therapeutics, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING6
READOUTS ≤12 MONTHS0
Open Kriya Therapeutics, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
VISION
NCT06765980
P1/2RecruitingGeographic Atrophy Secondary to Age-related Macular Degeneration622027-12-15
RESTORE
NCT07732400
P1/2RecruitingMetabolic Dysfunction-associated Steatohepatitis (MASH)562028-07
RECLAIM
NCT07404111
P1/2RecruitingThyroid Eye Disease (TED)1352028-08
RELIEVE
NCT07831798
P1/2RecruitingType 1 Diabetes Mellitus292028-11
RELIEF
NCT07596485
P1/2RecruitingTrigeminal Neuralgia242029-02
PROGRESS
NCT07829302
P1/2RecruitingType 1 Diabetes Mellitus292029-07